Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review

• 主要な著者: Sirui Tan (著者), Jing Yu (著者), Qiyue Huang (著者), Nan Zhou (著者), Xianze Xiong (著者), Hongfeng Gou (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Cholangiocarcinoma (CCA) is a highly aggressive malignant tumor with poor overall survival. Although the first-line standard chemotherapy (gemcitabine plus cisplatin) combined with immunotherapy has yielded positive results with survival prolongation, the efficacy remains unsatisfactory,...